Related Experiment Videos
Preliminary experience with plasma exchange in patients with ulcerative colitis
G Selset Aandahl1, C D Jacobsen, L Rode
1Department of Immunology, Central Hospital of Akershus, 1474, Nordbyhagen, Norway.
Summary
Plasma exchange (PE) shows potential benefits for ulcerative colitis (UC) patients with severe or fulminant disease unresponsive to conventional treatments. Long-term follow-up suggests sustained improvement in a significant portion of patients.
Area of Science:
- Gastroenterology
- Immunology
- Hematology
Background:
- Inflammatory bowel disease (IBD), including ulcerative colitis (UC), poses challenges when conventional therapies fail.
- Identifying effective alternative treatments for refractory IBD is crucial for improving patient outcomes.
Purpose of the Study:
- To evaluate the efficacy of plasma exchange (PE) as a treatment for selected patients with ulcerative colitis (UC) refractory to standard medical management.
- To assess both short-term and long-term effects of PE on disease activity and patient well-being.
Main Methods:
- A prospective study involving 12 patients with long-lasting severe UC who underwent PE (2 litres every 2-3 days, 5-6 sessions over 2 weeks) using fresh frozen plasma.
- Disease activity indices and histological evaluation of mucosal biopsies were used to assess treatment response.
- An additional six patients with fulminant colitis also received PE.
Main Results:
- In the prospective group of 12 patients, 9 showed reduced activity indices within two weeks post-treatment, with 6 experiencing over 35% reduction.
- Immediate clinical improvement was observed in 2 of 6 patients with fulminant colitis.
- Over a 2-14 year follow-up, 14 of 26 total treated patients reported marked and long-lasting improvement in their IBD.
Conclusions:
- Plasma exchange may offer a beneficial therapeutic option for specific subsets of ulcerative colitis patients, particularly those with severe or fulminant disease unresponsive to conventional treatments.
- While immediate effects were primarily noted in activity indices, long-term follow-up indicates sustained benefits for a notable proportion of patients.